Tim Uden, Author at European Medical Journal - Page 11 of 28

Reduced Diversity of HLA Class I Alleles May Contribute to the Early Manifestation of Breast Cancer in Carriers of the BRCA1 Mutation

Most female carriers of germline BRCA1 mutations develop breast and/or ovarian cancer. However, the penetrance of BRCA1 pathogenic variants…

Precision Medicine-Based Platform to Guide the Treatment of EML4-ALK Lung Cancers and Other Non-Small Cell Lung Cancers

Lung cancer (LC) remains the top cause of cancer-associated mortality worldwide, with a 10-year overall survival rate of only 5%.1…

Programmed Death-Ligand 1 Expression and its Relation to EML4-ALK Gene Variants in Metastatic Lung Adenocarcinoma: A Single Centre Real-World Experience

Targeted therapy and immunotherapy have revolutionised the treatment of metastatic non-small cell lung cancer, particularly adenocarcinoma…

ESMO 2023 Abstract Highlights

FOR the first time, there is an alternative to chemotherapy for patients with advanced or metastatic urothelial carcinoma. The results of a…

White Bagging Biosimilars: Navigating Access Challenges in Healthcare

At this year’s American College of Rheumatology (ACR) 2023 Convergence, held in San Diego, California, USA, between 10th–15th…

Evaluation of Bacteremia in Febrile Neutropenia and Implications on Antimicrobial Stewardship

Febrile neutropenia (FN) is a common complication in patients with cancer, and historically, pseudomonal infections have been attributed…

ADVENT Dermatology

ADVENT is a medical education non-promotional program for healthcare professionals organized by Sanofi and Regeneron…

Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas

Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…

Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity

Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…

IDWeek 2023 Abstract Highlights

They cover key topics, including disparities in sepsis management, methicillin-resistant Staphylococcus aureus decolonization…